SCHEMBL22747039

SCHEMBL22747039

c1ccc(-n2c3ccccc3c3cc(-c4cccc(-n5c6ccc(-c7nc8ccccc8o7)cc6c6cc(-c7nc8ccccc8o7)ccc65)c4)ccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.52
▸ ALDH1A1 P00352 7/20 0.52
▸ SMN1; SMN2 Q16637 6/20 0.52
▸ HPGD P15428 6/20 0.52
▸ HSD17B10 Q99714 5/20 0.52
▸ TP53 P04637 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ PKM P14618 1/20 0.52
▸ HPSE Q9Y251 3/20 0.46
▸ NPC1 O15118 7/20 0.45
▸ RAB9A P51151 5/20 0.45
▸ USP2 O75604 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HCRTR1 O43613 2/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ CASP3 P42574 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ SENP8 Q96LD8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23108422 0.98 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL22747043 0.97 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL23108466 0.97 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL10065406 0.95 HSD17B10 (0.49) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL22746738 0.94 KDM4E (0.55) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL10065298 0.94 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL23118822 0.94 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL22747032 0.93 NPC1 (0.46) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL27282344 0.93 NPC1 (0.46) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL23108789 0.93 KDM4E (0.50) KDM4EALDH1A1SMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377492-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME P&H TECH CO., LTD 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377492-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, POU2F1 KDM4E 1834/4885ALDH1A1 582/4885SMN1; SMN2 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback